Company / EPS (Diluted)
Bausch & Lomb Corp EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.74
FY2025
5-year range
-$0.74 / $0.52
FY2021-FY2025
Trend
-3800.0%
vs FY2024
Sector context
#116 of 159
Health Care
What the data says
EPS (Diluted) changed -3800% YoY in FY2025, a notable deviation from the 5-year average annual change of -345%.
Based on SEC 10-K filings.
-0.74 in FY2025.
Declined from $0.52 to $-0.74 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#116 of 159 in Health CareTop 73% of 159This company -$0.74 Sector average $1.66
▼
-144.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 3800.0% year-over-year.
- Ranks #116 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.74 | -3800.0% |
| FY2024 | $0.02 | -96.2% |
| FY2023 | $0.52 | +1140.0% |
| FY2022 | -$0.05 | -109.6% |
| FY2021 | $0.52 | +1140.0% |
| FY2020 | -$0.05 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026